Home › Funds › Catalio Capital Management, LP › NKTR
Catalio Capital Management, LP position in NKTR
NEKTAR THERAPEUTICS · Health Care
Catalio Capital Management, LP reported holding 126,817 shares of NKTR (NEKTAR THERAPEUTICS) in its Q3 2026 13F filing — a position valued at US$7.7M, representing 1.43% of its reported portfolio and ranking #29 among its reported holdings. Catalio Capital Management, LP first reported this position in Q3 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Catalio Capital Management, LP's NKTR position evolved
Catalio Capital Management, LP first disclosed a stake in NKTR in Q3 2026 at 126,817 shares (US$7.7M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 126.82K | $7.68M | New |
About NKTR and 13F data
NKTR (NEKTAR THERAPEUTICS) is a Health Care company. 50 other funds we track also report a position in NKTR — the largest reported positions include Two Seas Capital LP (US$202.6M), BVF INC/IL (US$129.2M), Prosight Management, LP (US$47.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NKTR
- Two Seas Capital LP 3.35M sh · $202.58M · Q3 2026
- BVF INC/IL 2.13M sh · $129.20M · Q3 2026
- Prosight Management, LP 785.00K sh · $47.53M · Q3 2026
- ARMISTICE CAPITAL, LLC 700.00K sh · $42.38M · Q3 2026
- Vestal Point Capital, LP 510.00K sh · $30.88M · Q3 2026
- BRAIDWELL LP 443.59K sh · $26.86M · Q3 2026
- ORBIMED ADVISORS LLC 384.52K sh · $23.28M · Q3 2026
- DAFNA Capital Management LLC 323.38K sh · $19.58M · Q3 2026
- 22NW, LP 281.12K sh · $17.02M · Q3 2026
- ADAR1 Capital Management, LLC 258.18K sh · $15.63M · Q3 2026
- SEVEN GRAND MANAGERS, LLC 240.00K sh · $14.53M · Q3 2026
- Bronte Capital Management Pty Ltd. 202.06K sh · $12.23M · Q3 2026
More on Catalio Capital Management, LP
FAQ
How long has Catalio Capital Management, LP held NKTR?
Catalio Capital Management, LP has disclosed NKTR holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Catalio Capital Management, LP's current position in NKTR?
As of Q3 2026, Catalio Capital Management, LP holds 126.82K shares of NKTR (NEKTAR THERAPEUTICS), valued at $7.68M, representing 1.43% of its reported portfolio and ranking #29.
Has Catalio Capital Management, LP been buying or selling NKTR?
In the latest 13F filing (Q3 2026), Catalio Capital Management, LP newly opened its position in NKTR.
Which other funds hold NKTR?
Other major institutional holders of NKTR include Two Seas Capital LP, BVF INC/IL, Prosight Management, LP, among 50 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.